SCHEMBL22064852

SCHEMBL22064852

O=P(O)(O)c1ccc(-c2cc(-c3ccc(P(=O)(O)O)cc3)cc(-c3ccc(P(=O)(O)O)cc3)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.52
CA4 P22748 1/20 0.52
CA5A P35218 1/20 0.52
ESR1 P03372 1/20 0.43
GRIK1 P39086 1/20 0.38
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ACP3 P15309 2/20 0.35
PGK1 P00558 3/20 0.35
PGK2 P07205 3/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
ABL1 P00519 1/20 0.35
ABCB1 P08183 1/20 0.35
BCR P11274 1/20 0.35
PTPN5 P54829 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953765 0.92 CA2 (0.60) CA2CA4CA5AESR1GRIK1
SCHEMBL22999982 0.92 CA2 (0.60) CA2CA4CA5AESR1GRIK1
SCHEMBL22999958 0.88 CA2 (0.52) CA2CA4CA5AESR1GRIK1
SCHEMBL22999964 0.83 ESR1 (0.46) CA2CA4CA5AESR1GRIK1
SCHEMBL2171752 0.83 CA2 (0.71) CA2CA4CA5AESR1LMNA
SCHEMBL26185636 0.82 CA2 (0.50) CA2CA4CA5AGRIK1LMNA
SCHEMBL753791 0.82 CA2 (0.71) CA2CA4CA5AALDH1A1ACP3
SCHEMBL28886060 0.82 ESR1 (0.55) CA2CA4CA5AESR1LMNA
SCHEMBL5582366 0.80 CA2 (0.48) CA2CA4CA5AGRIK1LMNA
SCHEMBL21160795 0.80 ESR1 (0.40) CA2CA4CA5AESR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114903028-B Erythrocyte cryoprotectant and preparation method and application thereof 华南理工大学 2023-10-17 CN claimed
CN-114903028-A Erythrocyte cryoprotectant and preparation method and application thereof 华南理工大学 2022-08-16 CN claimed
EP-3774001-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2021-02-17 EP claimed
US-20260125559-A1 SINGLE-CRYSTAL METAL-FREE HELICAL COVALENT POLYMERS UNIV CITY HONG KONG (HK) 2026-05-07 US disclosed
US-20240317785-A1 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF UTI LIMITED PARTNERSHIP (CA) 2024-09-26 US disclosed
US-12030774-B2 Surface-modified inorganic nitride, composition, thermally conductive material, and device with thermally conductive layer FUJIFILM CORPORATION (JP) 2024-07-09 US disclosed
US-12030774-B2 Surface-modified inorganic nitride, composition, thermally conductive material, and device with thermally conductive layer FUJIFILM CORPORATION (JP) 2024-07-09 US disclosed
EP-4304766-A1 MEMBRANE DEVICE Evove Ltd (GB) 2024-01-17 EP disclosed
CN-114903028-B Erythrocyte cryoprotectant and preparation method and application thereof 华南理工大学 2023-10-17 CN disclosed
CN-114903028-A Erythrocyte cryoprotectant and preparation method and application thereof 华南理工大学 2022-08-16 CN disclosed
WO-2022160045-A1 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF UTI LIMITED PARTNERSHIP (CA) 2022-08-04 WO disclosed
EP-3774001-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2021-02-17 EP disclosed
US-20200180957-A1 SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORPORATION (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240317785-A1 CHROMIUM PHOSPHONATE METAL-ORGANIC FRAMEWORKS, PROCESS FOR PREPARING THE SAME AND USES THEREOF PPIP5K2, IPMK, POF1B CA2 149/4885CA4 289/4885CA5A 701/4885
US-20260125559-A1 SINGLE-CRYSTAL METAL-FREE HELICAL COVALENT POLYMERS TPR, POF1B, TEC CA2 413/4885CA4 288/4885CA5A 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.